HK1014960A1 - Propiophenone derivatives and process for preparing the same - Google Patents
Propiophenone derivatives and process for preparing the sameInfo
- Publication number
- HK1014960A1 HK1014960A1 HK98119268A HK98119268A HK1014960A1 HK 1014960 A1 HK1014960 A1 HK 1014960A1 HK 98119268 A HK98119268 A HK 98119268A HK 98119268 A HK98119268 A HK 98119268A HK 1014960 A1 HK1014960 A1 HK 1014960A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparing
- same
- propiophenone derivatives
- propiophenone
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34740696 | 1996-12-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1014960A1 true HK1014960A1 (en) | 1999-10-08 |
Family
ID=18390010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98119268A HK1014960A1 (en) | 1996-12-26 | 1998-12-31 | Propiophenone derivatives and process for preparing the same |
Country Status (23)
Country | Link |
---|---|
US (1) | US6048842A (de) |
EP (1) | EP0850948B1 (de) |
KR (1) | KR100407029B1 (de) |
CN (1) | CN1094942C (de) |
AR (1) | AR010385A1 (de) |
AT (1) | ATE216704T1 (de) |
AU (1) | AU719726B2 (de) |
BG (1) | BG63546B1 (de) |
BR (1) | BR9706471B1 (de) |
CA (1) | CA2225439C (de) |
DE (1) | DE69712172T2 (de) |
DK (1) | DK0850948T3 (de) |
ES (1) | ES2176600T3 (de) |
HK (1) | HK1014960A1 (de) |
HU (1) | HU228514B1 (de) |
ID (1) | ID19290A (de) |
IL (1) | IL122666A (de) |
MY (1) | MY119350A (de) |
NO (1) | NO311804B1 (de) |
PT (1) | PT850948E (de) |
RU (1) | RU2156247C2 (de) |
TW (1) | TW406086B (de) |
ZA (1) | ZA9711560B (de) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1020944C (zh) * | 1990-01-30 | 1993-05-26 | 阿图尔-费希尔股份公司费希尔厂 | 紧固件 |
PH12000002657B1 (en) | 1999-10-12 | 2006-02-21 | Bristol Myers Squibb Co | C-aryl glucoside SGLT2 inhibitors |
US6515117B2 (en) | 1999-10-12 | 2003-02-04 | Bristol-Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
US6683056B2 (en) | 2000-03-30 | 2004-01-27 | Bristol-Myers Squibb Company | O-aryl glucoside SGLT2 inhibitors and method |
US6555519B2 (en) | 2000-03-30 | 2003-04-29 | Bristol-Myers Squibb Company | O-glucosylated benzamide SGLT2 inhibitors and method |
EP1338603B1 (de) | 2000-11-02 | 2010-01-20 | Ajinomoto Co., Inc. | Neue pyrazolderivate und diese enthaltende mittel gegen diabetes |
US6936590B2 (en) | 2001-03-13 | 2005-08-30 | Bristol Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
EP1392326B1 (de) * | 2001-04-04 | 2009-09-09 | Ortho-McNeil-Janssen Pharmaceuticals, Inc. | Kombinationstherapie durch glukoseresorptionshemmer und retinoid x rezeptorenmodulatoren |
WO2002080936A1 (en) * | 2001-04-04 | 2002-10-17 | Ortho Mcneil Pharmaceutical, Inc. | Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
CA2484306A1 (en) * | 2002-04-26 | 2003-11-06 | Katsumi Maezono | Prophylactic and therapeutic agent of diabetes mellitus |
US7956041B2 (en) | 2002-04-26 | 2011-06-07 | Ajinomoto Co., Inc. | Prophylactic and therapeutic agent of diabetes mellitus |
BR0310006A (pt) | 2002-08-09 | 2005-02-15 | Taisho Pharmaceutical Co Ltd | Derivados de 5-tio-beta-d-glicopiranosìdeo de arila e agentes terapêuticos para diabetes contendo os mesmos |
DE10258008B4 (de) * | 2002-12-12 | 2006-02-02 | Sanofi-Aventis Deutschland Gmbh | Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel |
DE10258007B4 (de) | 2002-12-12 | 2006-02-09 | Sanofi-Aventis Deutschland Gmbh | Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel |
TW200504021A (en) | 2003-01-24 | 2005-02-01 | Bristol Myers Squibb Co | Substituted anilide ligands for the thyroid receptor |
CA2549025A1 (en) * | 2003-08-01 | 2005-02-10 | Janssen Pharmaceutica N.V. | Substituted indole-o-glucosides |
EA009768B1 (ru) * | 2003-08-01 | 2008-04-28 | Янссен Фармацевтика Нв | Замещенные конденсированные гетероциклические с-гликозиды |
CA2549017A1 (en) * | 2003-08-01 | 2005-02-10 | Mona Patel | Substituted indazole-o-glucosides |
AR045173A1 (es) * | 2003-08-01 | 2005-10-19 | Tanabe Seiyaku Co | Compuestos que poseen actividad inhibitoria contra transportador de glucosa dependiente de sodio |
US8785403B2 (en) | 2003-08-01 | 2014-07-22 | Mitsubishi Tanabe Pharma Corporation | Glucopyranoside compound |
AR048377A1 (es) * | 2003-08-01 | 2006-04-26 | Janssen Pharmaceutica Nv | Benzoimidazol-, benzotriazol- y benzoimidazolona - o- glucosidos sustituidos |
FR2862303B1 (fr) * | 2003-11-17 | 2006-01-06 | Agronomique Inst Nat Rech | Preparations colorantes hydrosolubles jaunes derivees des dihydrochalcones, leur procede des preparation, et leurs utilisations |
DE102004028241B4 (de) | 2004-06-11 | 2007-09-13 | Sanofi-Aventis Deutschland Gmbh | Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel |
TW200606129A (en) * | 2004-07-26 | 2006-02-16 | Chugai Pharmaceutical Co Ltd | Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same |
TW200637869A (en) * | 2005-01-28 | 2006-11-01 | Chugai Pharmaceutical Co Ltd | The spiroketal derivatives and the use as therapeutical agent for diabetes of the same |
RU2437876C2 (ru) | 2006-05-19 | 2011-12-27 | Тайсо Фармасьютикал Ко., Лтд. | Соединение с-фенилглицитола для лечения диабета |
DE102006028862A1 (de) | 2006-06-23 | 2007-12-27 | Merck Patent Gmbh | 3-Amino-imidazo[1,2-a]pyridinderivate |
US8115017B2 (en) | 2006-06-29 | 2012-02-14 | Taisho Pharmaceutical Co., Ltd | C-phenyl 1-thioglucitol compound |
US7993687B2 (en) * | 2006-07-12 | 2011-08-09 | Julianne Marie Kawa | Compositions and methods for management of diabetes |
UY30730A1 (es) * | 2006-12-04 | 2008-07-03 | Mitsubishi Tanabe Pharma Corp | Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno |
CN101611023A (zh) | 2006-12-14 | 2009-12-23 | 大正制药株式会社 | 1-苯基1-硫代-d-山梨醇衍生物 |
DE102007008420A1 (de) | 2007-02-21 | 2008-08-28 | Merck Patent Gmbh | Benzimidazolderivate |
HUE035130T2 (en) * | 2007-09-10 | 2018-05-02 | Janssen Pharmaceutica Nv | A method for preparing compounds useful as SGLT inhibitors |
DE102007048716A1 (de) | 2007-10-11 | 2009-04-23 | Merck Patent Gmbh | Imidazo[1,2-a]pyrimidinderivate |
CL2008003653A1 (es) | 2008-01-17 | 2010-03-05 | Mitsubishi Tanabe Pharma Corp | Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica. |
DE102008017590A1 (de) | 2008-04-07 | 2009-10-08 | Merck Patent Gmbh | Glucopyranosidderivate |
CA2725047A1 (en) | 2008-05-22 | 2009-11-26 | Bristol-Myers Squibb Company | Method for treating hyperuricemia employing an sglt2 inhibitor and composition containing same |
BRPI0918841B8 (pt) | 2008-08-28 | 2021-05-25 | Pfizer | derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol, seus cristais, composições farmacêuticas e usos |
US9056850B2 (en) * | 2008-10-17 | 2015-06-16 | Janssen Pharmaceutica N.V. | Process for the preparation of compounds useful as inhibitors of SGLT |
US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
JP5658751B2 (ja) | 2009-07-10 | 2015-01-28 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプJanssen Pharmaceutica Naamloze Vennootschap | 1−(β−D−グルコピラノシル)−4−メチル−3−[5−(4−フルオロフェニル)−2−チエニルメチル]ベンゼンのための結晶化方法 |
EP2298782A1 (de) * | 2009-08-26 | 2011-03-23 | Sanofi-Aventis | Verfahren zur Herstellung von Pyrazol-glykosid-Derivate |
DK2488515T3 (en) * | 2009-10-14 | 2017-02-27 | Janssen Pharmaceutica Nv | PROCEDURE FOR THE PREPARATION OF COMPOUNDS USED AS INHIBITORS OF SGLT2 |
SI2496583T1 (sl) | 2009-11-02 | 2015-02-27 | Pfizer Inc. | Derivati dioksa-biciklo(3.2.1)oktan-2,3,4-triola |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
MX339570B (es) | 2010-05-11 | 2016-05-31 | Janssen Pharmaceutica Nv | Formulaciones farmaceuticas que comprenden derivados de 1-(beta-d-glucopiranosil)-2-tienil-metilbenceno como inhibidores de transportadores de glucosa dependientes de sodio. |
SI2697218T1 (sl) | 2011-04-13 | 2016-07-29 | Janssen Pharmaceutica Nv | Postopek za pripravo spojin, koristnih kot zaviralci sglt2 |
TWI542596B (zh) | 2011-05-09 | 2016-07-21 | 健生藥品公司 | (2s,3r,4r,5s,6r)-2-(3-((5-(4-氟苯基)噻吩-2-基)甲基)-4-甲基苯基)-6-(羥甲基)四氫-2h-哌喃-3,4,5-三醇之l-脯胺酸及檸檬酸共晶體 |
EP2774619B1 (de) | 2013-03-04 | 2016-05-18 | BioActive Food GmbH | Zusammensetzung zur Behandlung von hyperglykämischen Erkrankungen |
US20160033480A1 (en) * | 2013-12-16 | 2016-02-04 | Amy Huimeei Lo | Immunovir and Components, Immunovir A, B, C, D Utility and Useful Processes |
EP2944311A1 (de) | 2014-05-16 | 2015-11-18 | BioActive Food GmbH | Kombination von biologisch aktiven Substanzen zur Behandlung von hyperglykämischen Erkrankungen |
CN104478956A (zh) * | 2015-01-14 | 2015-04-01 | 佛山市赛维斯医药科技有限公司 | 苯基双o-葡萄糖苷衍生物、其制备方法和用途 |
CN104497068A (zh) * | 2015-01-15 | 2015-04-08 | 佛山市赛维斯医药科技有限公司 | 一种含三氟甲氧基苯s-葡萄糖苷结构的化合物及其用途 |
CN104478961A (zh) * | 2015-01-15 | 2015-04-01 | 佛山市赛维斯医药科技有限公司 | 含丙烯腈和胺基苯o-葡萄糖苷结构衍生物、其制备方法和用途 |
CN104497071A (zh) * | 2015-01-15 | 2015-04-08 | 佛山市赛维斯医药科技有限公司 | 一种含丙烯腈基和腈基苯o-葡萄糖苷结构化合物及用途 |
CN104497069A (zh) * | 2015-01-15 | 2015-04-08 | 佛山市赛维斯医药科技有限公司 | 一类胺基苯基s-葡萄糖苷衍生物、其制备方法和用途 |
US20170071970A1 (en) | 2015-09-15 | 2017-03-16 | Janssen Pharmaceutica Nv | Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders |
CN107827753A (zh) * | 2017-11-14 | 2018-03-23 | 湖北工业大学 | 一种对甲基二乙酰氧基碘苯的制备方法 |
EA202190226A1 (ru) | 2018-07-19 | 2021-06-16 | Астразенека Аб | СПОСОБЫ ЛЕЧЕНИЯ HFpEF С ИСПОЛЬЗОВАНИЕМ ДАПАГЛИФЛОЗИНА И СОДЕРЖАЩИХ ЕГО КОМПОЗИЦИЙ |
TW202220672A (zh) | 2020-07-27 | 2022-06-01 | 瑞典商阿斯特捷利康公司 | 用達格列淨治療慢性腎臟病之方法 |
WO2022208172A1 (en) | 2021-04-01 | 2022-10-06 | Astrazeneca Uk Limited | Systems and methods for managing prediabetes with a gliflozin sodium-glucose cotransport 2 inhibitor pharmaceutical composition |
WO2023144722A1 (en) | 2022-01-26 | 2023-08-03 | Astrazeneca Ab | Dapagliflozin for use in the treatment of prediabetes or reducing the risk of developing type 2 diabetes |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4031260A (en) * | 1971-05-14 | 1977-06-21 | Nutrilite Products, Inc. | Salts of dihydrochalcone derivatives and their use as sweeteners |
US3984394A (en) * | 1971-05-14 | 1976-10-05 | Nutrilite Products, Inc. | Salts of dihydrochalcone derivatives and their use as sweeteners |
US4684627A (en) * | 1981-09-08 | 1987-08-04 | Leveen Harry H | Treatment of cancer with phlorizin and its derivatives |
US5110801A (en) * | 1984-08-13 | 1992-05-05 | Leveen Harry H | Treatment of acne |
CA1289077C (en) * | 1984-08-13 | 1991-09-17 | Harry H. Leveen | Treatment of cancer with phlorizin and its derivatives |
US4760135A (en) * | 1984-09-06 | 1988-07-26 | University Of Kentucky Research Foundation | Phloretin and phlorizin derivative containing compounds |
US4665058A (en) * | 1985-03-16 | 1987-05-12 | The University Of Kentucky Research Foundation | Compositions and method of treatment for sickle cell anemia |
CA2102591C (en) * | 1992-11-12 | 2000-12-26 | Kenji Tsujihara | Hypoglycemic agent |
JP2847696B2 (ja) * | 1994-05-11 | 1999-01-20 | 田辺製薬株式会社 | プロピオフェノン誘導体及びその製法 |
US5830873A (en) * | 1994-05-11 | 1998-11-03 | Tanabe Seiyaku Co., Ltd. | Propiophenone derivative and a process for preparing the same |
JP3059088B2 (ja) * | 1995-11-07 | 2000-07-04 | 田辺製薬株式会社 | プロピオフェノン誘導体およびその製法 |
-
1997
- 1997-12-17 DK DK97122279T patent/DK0850948T3/da active
- 1997-12-17 TW TW086119107A patent/TW406086B/zh not_active IP Right Cessation
- 1997-12-17 ES ES97122279T patent/ES2176600T3/es not_active Expired - Lifetime
- 1997-12-17 EP EP97122279A patent/EP0850948B1/de not_active Expired - Lifetime
- 1997-12-17 AT AT97122279T patent/ATE216704T1/de active
- 1997-12-17 AU AU48416/97A patent/AU719726B2/en not_active Ceased
- 1997-12-17 PT PT97122279T patent/PT850948E/pt unknown
- 1997-12-17 DE DE69712172T patent/DE69712172T2/de not_active Expired - Lifetime
- 1997-12-18 US US08/993,523 patent/US6048842A/en not_active Expired - Lifetime
- 1997-12-18 IL IL12266697A patent/IL122666A/xx not_active IP Right Cessation
- 1997-12-18 MY MYPI97006145A patent/MY119350A/en unknown
- 1997-12-22 CA CA002225439A patent/CA2225439C/en not_active Expired - Fee Related
- 1997-12-23 HU HU9702534A patent/HU228514B1/hu not_active IP Right Cessation
- 1997-12-23 ID IDP973965A patent/ID19290A/id unknown
- 1997-12-23 BG BG102148A patent/BG63546B1/bg unknown
- 1997-12-23 NO NO19976072A patent/NO311804B1/no not_active IP Right Cessation
- 1997-12-24 CN CN97107281A patent/CN1094942C/zh not_active Expired - Fee Related
- 1997-12-25 RU RU97122334/04A patent/RU2156247C2/ru not_active IP Right Cessation
- 1997-12-26 BR BRPI9706471-8A patent/BR9706471B1/pt not_active IP Right Cessation
- 1997-12-26 KR KR1019970074439A patent/KR100407029B1/ko not_active IP Right Cessation
- 1997-12-26 AR ARP970106183A patent/AR010385A1/es active IP Right Grant
- 1997-12-26 ZA ZA9711560A patent/ZA9711560B/xx unknown
-
1998
- 1998-12-31 HK HK98119268A patent/HK1014960A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1014960A1 (en) | Propiophenone derivatives and process for preparing the same | |
AP9901444A0 (en) | Erythrommycins and process for their preparation | |
SG44166A1 (en) | Phenol compound and process for preparing the same | |
AU3734799A (en) | 5-demethoxyfumagillol derivatives and processes for preparing the same | |
HUP9800208A3 (en) | Omega-cycloalkyl-prostaglandin e2-derivatives and process for preparing them | |
AU4397597A (en) | Novel phytase and process for the preparation thereof | |
CZ20012118A3 (cs) | Způsob výroby 3-alkanoylindolu a 3-alkylindolu | |
AU4401397A (en) | Casein and process for the preparation thereof | |
ZA958161B (en) | Process for preparing 1,3-alkanediols and 3-hydroxyaldehydes | |
GB9826881D0 (en) | Coupled polymers and process for preparing the same | |
EP0990632A4 (de) | Adamantanmethanol-derivate und verfahren zu ihrer herstellung | |
ZA958160B (en) | Process for preparing 1,3-alkanediols and 3-hydroxyaldehydes | |
EP0890599A4 (de) | Polyorganosiloxane und verfahren zu deren herstellung | |
AP9801387A0 (en) | Sugar-coated products and process for preparing the same | |
AU7571194A (en) | Azotobacterin and the method for preparing the same | |
EP1001035A4 (de) | Antibiotika rk-1061 und verfahren zu ihrer herstellung | |
AU4068197A (en) | Brazing and preparing articles for brazing | |
AU3744495A (en) | Process for preparing 1,3-alkanediols and 3-hydroxyldehydes | |
IL126827A0 (en) | Substituted phenyluracils a process for their preparation and the use thereof | |
AU3218195A (en) | Alpha-d-pentofuranoside derivatives, process for preparing the same and their use | |
SG47141A1 (en) | Sulfonamide derivative and process for preparing the same | |
AU1733297A (en) | Novel tetrahydronaphthofuranone derivatives and process for producing the same | |
EP0943689A4 (de) | Verfahren zur herstellung von fr900482 und analoge verbindungen | |
HUP9902650A3 (en) | Butadiene derivatives and process for preparing thereof | |
GB2329385B (en) | (3-Oxoisoindolin-1-ylidine)propandinitrile derivatives and method for preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20151217 |